Medication prescribing in face-to-face versus telehealth consultations during the COVID-19 pandemic in Australian general practice: a retrospective observational study

Abstract

BackgroundThere has been a precipitous rise telehealth use in general practice during the COVID-19 pandemic. Understanding differences between face-to-face and telehealth consulting is an important component for planning the future use of telehealth services beyond the pandemic. However, there is limited evidence on whether telehealth consulting impacts medication prescribing under pandemic circumstances.AimTo compare medication prescribing in face-to-face versus telehealth consultations during the COVID-19 pandemic in Australian general practice.Design and SettingThis multisite, retrospective observational study used de-identified routinely collected electronic health data extracted from 806 general practices in Victoria and New South Wales (NSW), Australia between April-December 2020.MethodThe primary outcome measure was whether at least one medication was prescribed following a telehealth or face-to-face consultation. Data are reported by medication and for each of the Anatomical Therapeutic Chemical (ATC) Classification System level one groups. The secondary outcome measure was first-time prescribing. Telehealth included both telephone and video consultations.ResultsA total of 13,608,216 consultations satisfied the inclusion criteria (61% face-to-face and 39% telehealth). Most telehealth consultations were conducted via telephone (97.8%). Overall, 39.3% of face-to-face and 33.0% of telehealth consultations prescribed at least one medication– a statistically significant difference (adjusted OR 1.38; 95% CI 1.379–1.381). The prescribing rate was greater for face-to-face vs telehealth consultations for all drug groups except ATC level 1N (nervous system).ConclusionUnder COVID-19 restrictions in the states of Victoria and NSW, Australia, medication prescribing was higher in face-to-face consultations when compared to telehealth consultations in the study population.

General practice perspective on the use of telehealth during the COVID-19 pandemic in Australia using an Action Research approach: a qualitative study

“…Another study revealed that fewer medications were prescribed during telehealth consultations than in-person consults. 9 …”

Pharmacist and patient experiences of primary care during the COVID-19 pandemic: An interview study

“…, 29. , 30. A number of rapid and significant changes in the use of technology for patient care occurred during the COVID-19 pandemic, and while many have shown good acceptability among patients and healthcare professionals, the long-term impact on patient care is not yet clear.…”

Health seeking behavior and self-medication practice among undergraduate medical students of a teaching hospital: A cross-sectional study

“…During the coronavirus disease (COVID-19) pandemic, the mode of consultation of the patients has also switched to online in substitute to in-person consultation [ 24 ]. Patients have been looking for an alternative to face-to-face consultation, and online as well as telecommunication-based consultations are in practice [ [25] , [26] , [27] ]. More than half of the responders disregarded online consultation as a substitute for in-person consultation with the physician.…”